GLOBEALERT
Sign in

Feed

Open sources, classified and cross-checked. 1,091+ stories.

AllConflictMilitaryPoliticsBusinessSci & TechCyberDisasterHealthWorld
24h3 days7 days30 daysAll·All regionsNorth AmericaSouth AmericaWestern EuropeEastern EuropeBalticsMiddle EastNorth AfricaSub-Saharan AfricaSouth AsiaEast AsiaOceania
SCI & TECHJun 20Japan to enhance global cooperation on AI risksThe draft revision of the Artificial Intelligence Basic Plan highlights the growing risk of cyberattacks that exploit AI.japantimes · japan
SCI & TECHJun 19Indonesia to capture last-known wild Bornean rhino for IVFJAKARTA: Indonesia's government is racing to capture the last-known Bornean rhino in the wild in a bid to preserve the species through in-vitro fertilisation, a government official told AFP on Friday (June 19).thestar_my · malaysia
SCI & TECHJun 19Indonesia largest AI experiment barely has safety net - AcademiaIndonesia's largest AI experiment is noted to have minimal safety measures. This raises concerns about the safety protocols for significant technological advancements.thejakartapost.com · Indonesia
SCI & TECHJun 18Ag department continues attack on Japanese beetlesThe agriculture department is continuing its efforts to combat Japanese beetles. This news covers ongoing pest control measures in the agricultural sector.elkodaily.com · United States
SCI & TECHJun 18Japan green steel push gains ground but hurdles remain | Hellenic Shipping News WorldwideJapan's initiative to develop "green steel" is making progress, despite facing continuous challenges. This highlights advancements and obstacles in sustainable industrial development.hellenicshippingnews.com · China
SCI & TECHJun 18Check out three new Japanese commercials for Rhythm Heaven GrooveThree new Japanese commercials have been released for the video game 'Rhythm Heaven Groove'.gonintendo · united states of america
SCI & TECHJun 17Assassin Creed Shadows 1 . 0 . 33 for macOS – Epic action ‑ adventure RPG set in feudal Japan with dual protagonistsA new version of the action-adventure RPG 'Assassin's Creed Shadows' has been released for macOS, featuring a feudal Japan setting with dual protagonists.chilecomparte.cl · Chile
SCI & TECHJun 17Hell Let Loose : Vietnam Targets 60 FPS on Consoles , PSSR Support Coming in Post - Launch UpdateThe video game 'Hell Let Loose: Vietnam' aims for 60 frames per second on consoles and plans to introduce PSSR support in a future update, detailing performance and technical improvements for gamers.gamingbolt.com · Japan
SCI & TECHJun 17China homegrown airships lift off from test field into commercial skiesChina has launched its domestically developed airships from a test field for commercial use, marking a step forward in its aerospace technology and potential commercial applications.en.people.cn · China
SCI & TECHJun 16Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming LeadershipPluristyx issued Japan patent allowance for next-gen synthetic mRNA, accelerating non-viral, footprint-free iPSC generation for regenerative medicineglobenewswire_fr · france
SCI & TECHJun 16Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming LeadershipSEATTLE, June 16, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a Notice of Allowance for Patent Application No. 2023-552219. The licensed patent, titled "Engineered Expression Constructs to Increase Protein Expression from Synthetic Ribonucleic Acid (RNA)" (nationalization of International Application No. PCT/US2022/017880), represents a critical expansion of Pluristyx's intellectual property portfolio. These unique synthetic mRNA constructs stabilize mRNA and increase protein expression without need for modified nucleosides, microRNA sites, or immune-evading factors. This allowance comes at a pivotal moment for regenerative medicine in Japan. A global leader in induced pluripotent stem cell (iPSC) research, Japan established an accelerated regulatory framework for iPSC-derived products in 2015. More than 11 years later, the first two landmark commercial iPSC-derived cell therapies have been approved. Pluristyx is addressing this critical industry bottleneck in the transition from R&D to commercial use by applying its unique synthetic mRNA technology to rapidly generate safe, clinical-grade iPSCs able to be manufactured at large commercial scale. By optimizing expression kinetics of synthetic RNA with a multiplex of key pluripotency transcription factors, the Pluristyx platform ... Full story available on Benzinga.combenzinga · united states of america
← Newer